Clinical Trial

Resolving Early Life Stress: Psychotherapy Outcomes and Neurobiology in Complex Depression

Study acronym: RESPOND
Recruiting
View on ClinicalTrials.gov →
Summary
The RESPOND trial explores the link between early life adversity and later life depressive symptoms. The investigators have designed a new psychological therapy tailored to address the symptoms that can be caused by difficult experiences in early life. These symptoms include low mood, emotional dysregulation, and distressing thoughts and beliefs related to difficult or traumatic experiences. The investigators would like to see if this new therapy helps people feel better. The investigators are also studying the biological changes that can occur as a result of early life adversity, and how this therapy may influence those changes. To do this, the investigators ask questions about participants' physical and mental health and take blood samples.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-18; most recent amendment 2026-07-13.
Trial Details
NCT Number NCT07250893
Lead Sponsor St. Joseph's Healthcare Hamilton
Collaborators: Sun Life Financial Movement Disorders Research and Rehabilitation Centre
Conditions Depression - Major Depressive Disorder, Childhood Traumas
Enrollment 50 participants
Start Date 2025-10-25
Primary Completion 2027-08-15 (estimated)
Study Completion 2028-08-15 (estimated)
Updated on ClinicalTrials.gov 2026-07-14